Correspondence

A profusion of confusion in NGS methods naming

  • Subscribe to Nature Methods for full access:

    $59

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    and For all you seq, (Illumina, 2014).

  2. 2.

    Anonymous. Nat. Methods 8, 521 (2011).

  3. 3.

    et al. Nat. Methods 6, 377–382 (2009)

  4. 4.

    et al. Nat. Methods 10, 361–365 (2013).

  5. 5.

    et al. Genetics 202, 389–400 (2016).

Download references

Acknowledgements

We acknowledge the contribution of the many authors whose methods are referenced in this manuscript and apologize that restrictions on the number of references meant we did not list their work.

Author information

Affiliations

  1. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

    • James Hadfield
  2. Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, UK.

    • James Hadfield
  3. Illumina Inc., San Diego, California, USA. Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, UK.

    • Jacques Retief

Authors

  1. Search for James Hadfield in:

  2. Search for Jacques Retief in:

Competing interests

James Hadfield is the owner of the Enseqlopedia.com domain. Jacques Retief is currently employed by and owns shares in Illumina Inc., San Diego, California, USA.

Corresponding author

Correspondence to James Hadfield.